Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose.
about
Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphomaSolid tumor second primary neoplasms: who is at risk, what can we do?Evolved Cellular Mechanisms to Respond to Genotoxic Insults: Implications for Radiation-Induced Hematologic MalignanciesPediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine.Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer.Dosimetric advantages of a "butterfly" technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin's lymphomaNew Insights in the Cytogenetic Practice: Karyotypic Chaos, Non-Clonal Chromosomal Alterations and Chromosomal Instability in Human Cancer and Therapy ResponseBreast cancer after chest radiation therapy for childhood cancer.Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor StudyInconsistent mammography perceptions and practices among women at risk of breast cancer following a pediatric malignancy: a report from the Childhood Cancer Survivor Study.Risk of second breast cancer in female Hodgkin's lymphoma survivors: a meta-analysis.Use of appropriate initial treatment among adolescents and young adults with cancer.Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031Declining use of radiotherapy in stage I and II Hodgkin's disease and its effect on survival and secondary malignanciesMinimizing second cancer risk following radiotherapy: current perspectives.Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant miceThyroid functions in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy and radiotherapy.Secondary Malignancies Following Treatment for Hodgkin's Lymphoma in Childhood and AdolescenceIncidence and predictors of Lhermitte's sign among patients receiving mediastinal radiation for lymphomaImpact of low-dose involved-field radiation therapy on pediatric patients with lymphocyte-predominant Hodgkin lymphoma treated with chemotherapy: a report from the Children's Oncology Group.Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease.Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology GroupGenetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425.Secondary malignancies across the age spectrum.Radioprotection.Malignant melanoma as second malignant neoplasm in long-term childhood cancer survivors: a systematic review.The utility of FDG PET in diagnosis and follow-up of lymphoma in childhood.Secondary malignancies in pediatric cancer survivors: perspectives and review of the literature.A review of detrusor overactivity and the overactive bladder after radical prostate cancer treatment.[Radiotherapy in the treatment of advanced and recurrent prostate cancer].Persistent genomic instability in peripheral blood lymphocytes from Hodgkin lymphoma survivors.Age at exposure and attained age variations of cancer risk in the Japanese A-bomb and radiotherapy cohorts.Proton-beam therapy: are physicists ignoring clinical realities?Evaluation of surface and shallow depth dose reductions using a Superflab bolus during conventional and advanced external beam radiotherapy.Clinical Practice Recommendations Based on an Updated Review of Breast Cancer Risk Among Women Treated for Childhood Cancer.Management and Prevention of Breast Cancer After Radiation to the Chest for Childhood, Adolescent, and Young Adulthood Malignancy.Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma.Hodgkin disease therapy induced second malignancy susceptibility 6q21 functional variants in roma and hungarian population samples.Helical tomotherapy in the radiotherapy treatment of Hodgkin's disease ‐ a feasibility study.
P2860
Q24632704-A4CF2A58-460F-463C-AD28-7EC3C9CA24ACQ27026266-551F4E99-A350-4256-A3DD-5FD32BD2FE21Q28085534-7366D512-9A30-420A-A004-612F3B0C2BA4Q30248284-3D8F90EB-CA92-4A11-ADD8-DBF4F0A37A25Q33549627-4254E563-FC77-4B9A-9412-E3CBD1ECDECFQ33579820-FD5635A5-7850-400B-9903-300781F77A57Q33836777-017E1DEA-0CAB-4E26-AC4F-C35FEBBC8F28Q33910979-4B007A04-9158-47A1-8F69-4EEECB118A2EQ34008980-1CECE777-7268-461E-89EE-C0199457EE55Q34137800-8B70E0CE-FBF8-41F3-8CA4-7E770A13B6DEQ34284202-A2621F78-40B8-4796-B301-303AD5C741ECQ34354175-4D60A3C3-8CB6-4C0A-9D73-1221EF5E02D3Q34451778-81F2D8AB-BF62-41B3-8E40-198DD157256BQ34473445-9EAFD569-033C-42B5-94C2-0370412C9C90Q34757180-B713038F-6C14-46B5-91BA-905E97A51D6AQ34799331-43BFD49D-3964-4ADF-BC6A-CFD041972644Q35058057-6C7CF777-A5AA-4C62-92D3-E7875EB83882Q35682335-37D2EFF9-731F-4C3F-A686-7223B58671A6Q36092482-DBB5D893-DCD5-4C3E-89ED-E83230AA2183Q36309989-69839EA9-700D-42E4-9BD7-9E248AFF4CE9Q36898355-C5E83DE2-E8A2-48EE-A071-6040C65C4B32Q37169352-7980C82D-9029-4BD1-940D-2B60F627D9E7Q37207597-D5911480-D0A2-4DE7-BECF-039F4CE12A3EQ37348243-A6F00D08-4FC5-4348-96E3-A88B006DAE39Q37379773-0FB305F5-2DB2-4BBD-A91B-9416B7278EF8Q37469646-485478A7-9DDB-489A-86C3-FC1F38DA4E10Q37974615-7105FB1B-4361-43C7-AACF-32523FDE633CQ38096322-7F621E58-8AF0-433A-9A38-DD32B8271F87Q38221521-63EFC0CC-A90E-4CEC-B9F8-2F72BD83D0BFQ38356515-E573F7AF-C56C-4046-BCF4-17EA9BD78456Q39238392-00520A15-EFE3-42CA-9606-0D64B15ADAFCQ39638456-0F3C64F6-98D8-498B-9324-F57F5D5671D7Q40670436-4541E91C-53CF-4B37-A738-8A3DE9F7A278Q40807241-3A04ABCD-EFAC-4A6E-BF8B-68BC3A6E9379Q48503112-1BCEDC23-D402-4A62-9098-64252C78F737Q50234797-E28A1931-1916-48E2-8350-80394E0197FDQ51279958-F470E9CF-D1C2-4470-A872-83B7FA11AEA1Q53241145-AF7C6C92-DA14-44AE-810B-4A67DAD9F701Q54488797-75021528-305C-4217-9177-51A727757A23Q54995111-010D10A0-41FD-4E38-8CBB-614988315928
P2860
Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Subsequent malignancies in chi ...... ith gender and radiation dose.
@ast
Subsequent malignancies in chi ...... ith gender and radiation dose.
@en
type
label
Subsequent malignancies in chi ...... ith gender and radiation dose.
@ast
Subsequent malignancies in chi ...... ith gender and radiation dose.
@en
prefLabel
Subsequent malignancies in chi ...... ith gender and radiation dose.
@ast
Subsequent malignancies in chi ...... ith gender and radiation dose.
@en
P2093
P2860
P1476
Subsequent malignancies in chi ...... ith gender and radiation dose.
@en
P2093
Ajay Sandhu
Ann G Muhs
Cindy Schwartz
Eva Culakova
Gary Lyman
Larry E Kun
Louis S Constine
Melissa M Hudson
Nancy Tarbell
P2860
P356
10.1016/J.IJROBP.2008.04.067
P407
P577
2008-09-01T00:00:00Z